nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of association between polymorphisms in the pfcoronin and pfk13 genes and the presence of Plasmodium falciparum parasites after treatment with artemisinin derivatives in Senegal
|
Delandre, Océane |
|
|
56 |
6 |
p. |
artikel |
2 |
Ampicillin triggers the release of Pal in toxic vesicles from Escherichia coli
|
Michel, Lea Vacca |
|
|
56 |
6 |
p. |
artikel |
3 |
Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli
|
McKernan, Patrick |
|
|
56 |
6 |
p. |
artikel |
4 |
Antibody-based strategies in HIV therapy
|
Kufel, Wesley D. |
|
|
56 |
6 |
p. |
artikel |
5 |
A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa
|
van den Bergh, Dena |
|
|
56 |
6 |
p. |
artikel |
6 |
Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2
|
Alkotaji, Myasar |
|
|
56 |
6 |
p. |
artikel |
7 |
Bacteriophage–antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model
|
Wang, Lei |
|
|
56 |
6 |
p. |
artikel |
8 |
Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections
|
Veve, Michael P. |
|
|
56 |
6 |
p. |
artikel |
9 |
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
|
Derwand, Roland |
|
|
56 |
6 |
p. |
artikel |
10 |
Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland
|
Falgenhauer, Linda |
|
|
56 |
6 |
p. |
artikel |
11 |
Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics
|
Oany, Arafat Rahman |
|
|
56 |
6 |
p. |
artikel |
12 |
Development of a new spectrophotometric assay for rapid detection and differentiation of KPC, MBL and OXA-48 carbapenemase-producing Klebsiella pneumoniae clinical isolates
|
Routsias, John G. |
|
|
56 |
6 |
p. |
artikel |
13 |
Does the mode of dispersion determine the properties of dispersed Pseudomonas aeruginosa biofilm cells?
|
Wille, Jasper |
|
|
56 |
6 |
p. |
artikel |
14 |
Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients
|
Nori, Priya |
|
|
56 |
6 |
p. |
artikel |
15 |
Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis
|
Oscanoa, Teodoro J. |
|
|
56 |
6 |
p. |
artikel |
16 |
Genomic and phenotypic characterisation of antimicrobial resistance in carbapenem-resistant Acinetobacter baumannii hyperendemic clones CC1, CC15, CC79 and CC25
|
Camargo, Carlos Henrique |
|
|
56 |
6 |
p. |
artikel |
17 |
Genomic trajectories to fluoroquinolone resistance in Francisella tularensis subsp. holarctica live vaccine strain
|
Sutera, Vivien |
|
|
56 |
6 |
p. |
artikel |
18 |
High-risk clones and novel sequence type ST4497 of Klebsiella pneumoniae clinical isolates producing different alleles of NDM-type and other carbapenemases from a single tertiary-care centre in Egypt
|
Gamal, Doaa |
|
|
56 |
6 |
p. |
artikel |
19 |
Immunomodulatory effects of colistin on host responses against carbapenem-resistant Klebsiella pneumoniae biofilms
|
Geladari, Anastasia |
|
|
56 |
6 |
p. |
artikel |
20 |
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
|
|
|
|
56 |
6 |
p. |
artikel |
21 |
In vitro activity of eravacycline and mechanisms of resistance in enterococci
|
Boukthir, Sarrah |
|
|
56 |
6 |
p. |
artikel |
22 |
In vitro activity of eravacycline compared with tigecycline against carbapenem-resistant Enterobacteriaceae
|
Clark, Justin A. |
|
|
56 |
6 |
p. |
artikel |
23 |
Methylene blue inhibits replication of SARS-CoV-2 in vitro
|
Gendrot, Mathieu |
|
|
56 |
6 |
p. |
artikel |
24 |
Outpatient antibiotic use associated with acute upper respiratory infections in China: a nationwide cross-sectional study
|
Zhao, Houyu |
|
|
56 |
6 |
p. |
artikel |
25 |
Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March–June 2020
|
Ly, Tran Duc Anh |
|
|
56 |
6 |
p. |
artikel |
26 |
Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study
|
Dhibar, Deba Prasad |
|
|
56 |
6 |
p. |
artikel |
27 |
Preferences regarding antibiotic treatment and the role of antibiotic resistance: A discrete choice experiment
|
Ancillotti, M. |
|
|
56 |
6 |
p. |
artikel |
28 |
Preparation and physicochemical stability of 50 mg/mL hydroxychloroquine oral suspension in SyrSpendⓇ SF PH4 (dry)
|
Binson, Guillaume |
|
|
56 |
6 |
p. |
artikel |
29 |
Projected supportive effects of PycnogenolⓇ in patients suffering from multi-dimensional health impairments after a SARS-CoV2 infection
|
Weichmann, Franziska |
|
|
56 |
6 |
p. |
artikel |
30 |
Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update
|
del Barrio-Tofiño, Ester |
|
|
56 |
6 |
p. |
artikel |
31 |
Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection
|
AbdelKhalek, Ahmed |
|
|
56 |
6 |
p. |
artikel |
32 |
‘Reviewer Thank You List 2020’
|
|
|
|
56 |
6 |
p. |
artikel |
33 |
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter?
|
Vergori, A. |
|
|
56 |
6 |
p. |
artikel |
34 |
Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections
|
Bassetti, Matteo |
|
|
56 |
6 |
p. |
artikel |
35 |
Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices
|
Imani, Sahand |
|
|
56 |
6 |
p. |
artikel |
36 |
Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
|
Ramezankhani, Roya |
|
|
56 |
6 |
p. |
artikel |
37 |
The role of antibiotic pharmacokinetic studies performed post-licensing
|
Parker, Suzanne L. |
|
|
56 |
6 |
p. |
artikel |
38 |
Title Page & Editorial Board
|
|
|
|
56 |
6 |
p. |
artikel |
39 |
Treatment of infections caused by Gram-negative pathogens: current status on the pharmacokinetics/pharmacodynamics of parenteral and inhaled polymyxins in patients
|
Lin, Yu-Wei |
|
|
56 |
6 |
p. |
artikel |
40 |
World Antibiotic Awareness Week and European Antibiotic Awareness Day, November 2018: An analysis of the impact of Twitter activity
|
Mackenzie, Douglas Graham |
|
|
56 |
6 |
p. |
artikel |